These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24564933)

  • 1. The separate impact of tight control schemes and disease activity on quality of life in patients with early rheumatoid arthritis: results from the CAMERA trials.
    Jurgens MS; Welsing PM; Geenen R; Bakker MF; Schenk Y; de Man YA; Bijlsma JW; Lafeber FP; Jacobs JW
    Clin Exp Rheumatol; 2014; 32(3):369-76. PubMed ID: 24564933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase of body mass index in a tight controlled methotrexate-based strategy with prednisone in early rheumatoid arthritis: side effect of the prednisone or better control of disease activity?
    Jurgens MS; Jacobs JW; Geenen R; Bossema ER; Bakker MF; Bijlsma JW; van Albada-Kuipers IA; Ehrlich JC; Lafeber FP; Welsing PM;
    Arthritis Care Res (Hoboken); 2013 Jan; 65(1):88-93. PubMed ID: 22807253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial.
    Bakker MF; Jacobs JW; Welsing PM; Verstappen SM; Tekstra J; Ton E; Geurts MA; van der Werf JH; van Albada-Kuipers GA; Jahangier-de Veen ZN; van der Veen MJ; Verhoef CM; Lafeber FP; Bijlsma JW;
    Ann Intern Med; 2012 Mar; 156(5):329-39. PubMed ID: 22393128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis: an indirect comparison of effectiveness and safety of the U-Act-Early and CAMERA-II treat-to-target trials.
    Verhoeven MM; de Hair MJ; Tekstra J; Bijlsma JW; van Laar JM; Pethoe-Schramm A; Borm ME; Ter Borg EJ; Linn-Rasker SP; Teitsma XM; Lafeber FP; Jacobs JW; Welsing PM
    Ann Rheum Dis; 2019 Oct; 78(10):1333-1338. PubMed ID: 31196844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are switches from oral to subcutaneous methotrexate or addition of ciclosporin to methotrexate useful steps in a tight control treatment strategy for rheumatoid arthritis? A post hoc analysis of the CAMERA study.
    Bakker MF; Jacobs JW; Welsing PM; van der Werf JH; Linn-Rasker SP; van der Veen MJ; Lafeber FP; Bijlsma JW;
    Ann Rheum Dis; 2010 Oct; 69(10):1849-52. PubMed ID: 20511610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A tight control treatment strategy aiming for remission in early rheumatoid arthritis is more effective than usual care treatment in daily clinical practice: a study of two cohorts in the Dutch Rheumatoid Arthritis Monitoring registry.
    Schipper LG; Vermeer M; Kuper HH; Hoekstra MO; Haagsma CJ; Den Broeder AA; van Riel P; Fransen J; van de Laar MA
    Ann Rheum Dis; 2012 Jun; 71(6):845-50. PubMed ID: 22210852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In early inflammatory polyarthritis more intensive management according to the 2010 ACR/EULAR criteria leads to higher rates of clinical remission: comparison of two cohorts treated according to different treat-to-target protocols.
    Balduzzi S; Scirè CA; Sakellariou G; Benaglio F; Bugatti S; Montecucco C; Caporali R
    Clin Exp Rheumatol; 2017; 35(3):401-405. PubMed ID: 27974097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoids in the treatment of rheumatoid arthritis: still used after 65 years.
    Bijlsma JW; Jacobs JW
    Ann N Y Acad Sci; 2014 May; 1318():27-31. PubMed ID: 24641732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of different combinations of DMARDs and glucocorticoid bridging in early rheumatoid arthritis: two-year results of CareRA.
    Stouten V; Westhovens R; Pazmino S; De Cock D; Van der Elst K; Joly J; Verschueren P;
    Rheumatology (Oxford); 2019 Dec; 58(12):2284-2294. PubMed ID: 31236568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial.
    Hørslev-Petersen K; Hetland ML; Junker P; Pødenphant J; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Horn HC; Ammitzbøll CG; Jørgensen A; Krintel SB; Raun J; Johansen JS; Østergaard M; Stengaard-Pedersen K;
    Ann Rheum Dis; 2014 Apr; 73(4):654-61. PubMed ID: 23434570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial.
    Verschueren P; De Cock D; Corluy L; Joos R; Langenaken C; Taelman V; Raeman F; Ravelingien I; Vandevyvere K; Lenaerts J; Geens E; Geusens P; Vanhoof J; Durnez A; Remans J; Vander Cruyssen B; Van Essche E; Sileghem A; De Brabanter G; Joly J; Meyfroidt S; Van der Elst K; Westhovens R
    Ann Rheum Dis; 2015 Jan; 74(1):27-34. PubMed ID: 25359382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial).
    Verstappen SM; Jacobs JW; van der Veen MJ; Heurkens AH; Schenk Y; ter Borg EJ; Blaauw AA; Bijlsma JW;
    Ann Rheum Dis; 2007 Nov; 66(11):1443-9. PubMed ID: 17519278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse events and factors associated with toxicity in patients with early rheumatoid arthritis treated with methotrexate tight control therapy: the CAMERA study.
    Verstappen SM; Bakker MF; Heurkens AH; van der Veen MJ; Kruize AA; Geurts MA; Bijlsma JW; Jacobs JW;
    Ann Rheum Dis; 2010 Jun; 69(6):1044-8. PubMed ID: 19581281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CAMERA (Computer-Assisted Management in Early Rheumatoid Arthritis) studies.
    Jacobs JW
    Clin Exp Rheumatol; 2012; 30(4 Suppl 73):S39-43. PubMed ID: 23078796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal use of non-biologic therapy in the treatment of rheumatoid arthritis.
    Jacobs JW
    Rheumatology (Oxford); 2012 Jun; 51 Suppl 4():iv3-8. PubMed ID: 22513146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study.
    Allaart CF; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Breedveld FC; Dijkmans BA;
    Clin Exp Rheumatol; 2006; 24(6 Suppl 43):S-77-82. PubMed ID: 17083767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical effect of glucocorticoids in patients with rheumatoid arthritis may be masked by decreased use of additional therapies.
    van Everdingen AA; Siewertsz van Reesema DR; Jacobs JW; Bijlsma JW
    Arthritis Rheum; 2004 Apr; 51(2):233-8. PubMed ID: 15077265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of rituximab on physical function and quality of life in patients with rheumatoid arthritis previously untreated with methotrexate.
    Rigby W; Ferraccioli G; Greenwald M; Zazueta-Montiel B; Fleischmann R; Wassenberg S; Ogale S; Armstrong G; Jahreis A; Burke L; Mela C; Chen A
    Arthritis Care Res (Hoboken); 2011 May; 63(5):711-20. PubMed ID: 21557525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The multi-biomarker disease activity test for assessing response to treatment strategies using methotrexate with or without prednisone in the CAMERA-II trial.
    Jurgens MS; Safy-Khan M; de Hair MJH; Bijlsma JWJ; Welsing PMJ; Tekstra J; Lafeber FPJG; Sasso EH; Jacobs JWG;
    Arthritis Res Ther; 2020 Sep; 22(1):205. PubMed ID: 32907614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis.
    Pincus T; Castrejon I; Yazici Y
    Ann Intern Med; 2012 Aug; 157(4):299; author reply 300. PubMed ID: 22910946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.